- CDC
- Heart Failure
- Cardiovascular Clinical Consult
- Adult Immunization
- Hepatic Disease
- Rare Disorders
- Pediatric Immunization
- Implementing The Topcon Ocular Telehealth Platform
- Weight Management
- Monkeypox
- Guidelines
- Men's Health
- Psychiatry
- Allergy
- Nutrition
- Women's Health
- Cardiology
- Substance Use
- Pediatrics
- Kidney Disease
- Genetics
- Complimentary & Alternative Medicine
- Dermatology
- Endocrinology
- Oral Medicine
- Otorhinolaryngologic Diseases
- Pain
- Gastrointestinal Disorders
- Geriatrics
- Infection
- Musculoskeletal Disorders
- Obesity
- Rheumatology
- Technology
- Cancer
- Nephrology
- Anemia
- Neurology
- Pulmonology
Malignant Melanoma on a Patient’s Back
The only impressive thing about this lesion was a “notch” in its superior pole, and some mild pigment heterogeneity. Prudent caution proved extremely beneficial. The history of a “new” lesion in a patient with almost no visible nevi, along with some very subtle gross features, led to early recognition and elimination of a malignant melanoma.
A 44-year-old man was concerned about an asymptomatic dark lesion on his upper back, which his spouse alleged was “new.” The rest of the examination was normal. Family and past medical histories were non-contributory.
Key point: The lesion is not very impressive, either in size or in morphologic features. However, on close examination, there is a “notch” in the superior pole, as well as some mild degree of pigment heterogeneity.
Treatment: The patient was quite happy to have the lesion excised with 5-mm margins. Histology disclosed a malignant melanoma in situ.
Note: In this case, being prudently cautious proved extremely beneficial. The history of a “new” lesion in a patient with almost no visible nevi, along with some very subtle gross features, led to the early recognition and elimination of a malignant melanoma.
Biden Administration Announces First 10 Prescription Drugs Slated for Price Negotiations
August 29th 2023The first 10 drugs identified for negotiations under the Inflation Reduction Act include several well advertised agents indicated to treat diabetes, heart failure, and other chronic diseases.
